Skip to content

Evaluation of the efficacy for gastrointestinal condition and safety of boiled rice with higher resistant starch content.

Evaluation of the efficacy for gastrointestinal condition and safety of boiled rice with higher resistant starch content. - Evaluation of the efficacy for gastrointestinal condition and safety of boiled rice with higher resistant starch content.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028791
Enrollment
30
Registered
2017-08-31
Start date
2017-08-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Test food : 4 week intake of boiled rice with higher resistant starch content. ( 200 g / day ) Placebo food : 4 week intake of boiled rice of Koshihikari (200g / day )

Sponsors

Niigata Bio-Research Park, Inc
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Volunteer having screening test result and questionnaire result judged to be appropriate for this study by investigator.

Exclusion criteria

Exclusion criteria: 1.Diabetes under medical treatment. 2.Volunteers having diseases ( e.g. liver, kidney, heart, blood diseases, and infections requiring the notification). 3.Volunteers received gastrectomy, enterectomy, and garstro-intestinal diseases, judged to be inappropriate for this study. 4.Pregnant, woman having the possibility, and lactating women. 5.Paticipants in other clinical trial. 6.Volunteers rejected participating in this study by chief investigator.

Design outcomes

Primary

MeasureTime frame
Defecation frequency and fecal characteristics.

Secondary

MeasureTime frame
Safety.

Countries

Japan

Contacts

Public ContactHiroshi Goto

Niigata Bio-Research Park, Inc Business promotion division

goto@nbrp.co.jp0250-25-1196

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026